1,5-anhydroglucitol Blood Test More Accurate than HbA1c and Glucose for Predicting Mortality COVID-19 Patients with and without Diabetes

This week, Precision Diabetes, Inc. presented data demonstrating that the 1,5-anhydroglucitol blood test (GlycoMark®) is more accurate than commonly used diabetes tests in predicting mortality in hospitalized COVID-19 patients with and without diabetes. The study, “1,5-anhydroglucitol is an Independent Predictor of Mortality in Patients with COVID-19,” was presented at the American Heart Association (AHA) 2021 Scientific Sessions conference.

The study, conducted at Sinai Hospital in Baltimore, Md., showed that the GlycoMark® test had 76% mortality accuracy (AUC) compared to the accuracy for HbA1c and fasting glucose of 51% and 60%, respectively. The accuracy of GlycoMark was higher in patients without diabetes (79%) than in patients with diabetes (73%). An algorithm, which included age, BMI, and GlycoMark had an accuracy for prediction of mortality of 89%.

“We were pleased to find that the GlycoMark test identified mortality with high accuracy in COVID-19 patients,” says Paul Gurbel, MD, a cardiologist at the The LifeBridge Health Cardiovascular Institute and lead investigator of the trial. “GlycoMark may have utility in triaging COVID-19 patients in the hospital setting at higher risk of severity and mortality. This may be especially important in COVID-19 non-diabetic patients who may develop new-onset diabetes, which brings higher risks of severe disease and death.”

This study follows a previously reported study presented as a late-breaking abstract at the 2021 American Diabetes Association (ADA) Scientific Sessions, which showed that GlycoMark was an effective marker of stress hyperglycemia and severity in COVID-19 patients, particularly in patients without diabetes. The study was conducted at Hospital Universitario Cruces in Bilbao, Spain.

You may also like

  • A Determination to Succeed: The Remarkable Life and Career of Rosalyn Yalow, PhD

    Rosalyn Yalow, PhD, became the first woman to serve as the Endocrine Society’s president in 1977, the same year she received the Nobel Prize for Physiology or Medicine for developing the radioimmunoassay technique for hormone measurement. Endocrine News salutes this notable “grand dame of science” with a look at her life and career, as well…

  • Gut Bacteria May Play a Role in Diabetes

    One type of bacteria found in the gut may contribute to the development of type 2 diabetes, while another may protect from the disease, according to early results from an ongoing, prospective study recently published in Diabetes.   Researchers led by Mark Goodarzi, MD, PhD, director of the Endocrine Genetics Laboratory at Cedars-Sinai Medical Center…